| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 163.234 | 198.960 | 269.888 | 427.851 | 487.463 | 542.781 |
| Total Income - EUR | - | - | - | - | 177.639 | 206.180 | 269.893 | 437.507 | 487.463 | 542.784 |
| Total Expenses - EUR | - | - | - | - | 161.779 | 201.842 | 235.420 | 392.991 | 422.283 | 457.660 |
| Gross Profit/Loss - EUR | - | - | - | - | 15.860 | 4.338 | 34.473 | 44.516 | 65.180 | 85.124 |
| Net Profit/Loss - EUR | - | - | - | - | 14.228 | 2.496 | 31.809 | 40.957 | 61.456 | 71.431 |
| Employees | - | - | - | - | 3 | 4 | 1 | 2 | 2 | 4 |
Check the financial reports for the company - Neoped Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 100.921 | 134.447 | 112.315 | 87.171 | 65.521 | 45.029 |
| Current Assets | - | - | - | - | 5.940 | 16.376 | 27.266 | 32.618 | 86.082 | 144.596 |
| Inventories | - | - | - | - | 3.319 | 7.864 | 5.681 | 13.193 | 23.257 | 33.361 |
| Receivables | - | - | - | - | 1.914 | 7.074 | 17.842 | 4.236 | 4.435 | 71.556 |
| Cash | - | - | - | - | 707 | 1.438 | 3.743 | 15.189 | 58.389 | 39.680 |
| Shareholders Funds | - | - | - | - | -9.860 | -7.177 | 22.019 | 38.109 | 99.449 | 71.511 |
| Social Capital | - | - | - | - | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | - | - | 110.748 | 158.000 | 117.562 | 81.680 | 52.154 | 118.114 |
| Income in Advance | - | - | - | - | 5.973 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neoped Medica Srl